Oncology and Hematology

177-192 of 612

Expanding Cancer Detection: How MCED Testing Complements Standard Screening
Expanding Cancer Detection: How MCED Testing Complements Standard Screening
Project Oncology®
Expanding Cancer Detection: How MCED Testing Complements Standard Screening
- Jennifer Caudle, DO, FACOFP
- Patrick McGill, MD
Global Perspectives on Perioperative Immunotherapy in LA HNSCC
Global Perspectives on Perioperative Immunotherapy in LA HNSCC
CME/CE
Global Perspectives on Perioperative Immunotherapy in LA HNSCC
0.25 credits
- Kevin J Harrington, PhD, FRCP, FRCR, FRSB
- Christophe Le Tourneau, MD, PhD
0.25 credits
Monitoring Adverse Events Post-CAR T: The Latest Approaches and Best Practices
Monitoring Adverse Events Post-CAR T: The Latest Approaches and Best Practices
Project Oncology®
Monitoring Adverse Events Post-CAR T: The Latest Approaches and Best Practices
- Charles Turck, PharmD, BCPS, BCCCP
- Evandro Bezerra, MD
Mutational Complexity in ROS1-Positive mNSCLC: Insights from Real-World Practice
Mutational Complexity in ROS1-Positive mNSCLC: Insights from Real-World Practice
Project Oncology®
Mutational Complexity in ROS1-Positive mNSCLC: Insights from Real-World Practice
Postcolonoscopy Colorectal Cancer: Optimizing Quality to Reduce Risk
Postcolonoscopy Colorectal Cancer: Optimizing Quality to Reduce Risk
Clinician's Roundtable
Postcolonoscopy Colorectal Cancer: Optimizing Quality to Reduce Risk
- Aasma Shaukat, MD, MPH
Blood-Based Screening for Colorectal Cancer: Benefits and Limitations
Blood-Based Screening for Colorectal Cancer: Benefits and Limitations
Clinician's Roundtable
Blood-Based Screening for Colorectal Cancer: Benefits and Limitations
- Aasma Shaukat, MD, MPH
Diagnosing and Staging Non-Small Cell Lung Cancer: Key Updates and Evolving Strategies
Diagnosing and Staging Non-Small Cell Lung Cancer: Key Updates and Evolving Strategies
Global Oncology Academy
Diagnosing and Staging Non-Small Cell Lung Cancer: Key Updates and Evolving Strategies
- Gerard A. Silvestri MD, MS, Master FCCP
- Jeffrey B. Velotta, MD, FACS
- Anne Gonzalez, MD, M.Sc.
Optimizing NSCLC Care: Advances in Lung Biopsy and Biomarker Testing
Optimizing NSCLC Care: Advances in Lung Biopsy and Biomarker Testing
Global Oncology Academy
Optimizing NSCLC Care: Advances in Lung Biopsy and Biomarker Testing
- Gerard A. Silvestri MD, MS, Master FCCP
- Fabien Maldonado, MD, FCCP
- Adam H. Fox, MD, MSc
Advancing Noninvasive CRC Screening: Exploring an Aptamer-Based Assay
Advancing Noninvasive CRC Screening: Exploring an Aptamer-Based Assay
Project Oncology®
Advancing Noninvasive CRC Screening: Exploring an Aptamer-Based Assay
- Ryan Quigley
- Hallie Blevins, PhD
- Marlene Mimi Maeusli, PhD.
Differentiating Large Cell Neuroendocrine Carcinoma from Other Lung Cancers
Differentiating Large Cell Neuroendocrine Carcinoma from Other Lung Cancers
Project Oncology®
Differentiating Large Cell Neuroendocrine Carcinoma from Other Lung Cancers
- Balazs Halmos, MD, MS
Large Cell Neuroendocrine Carcinoma Care: A Look at Evolving Approaches
Large Cell Neuroendocrine Carcinoma Care: A Look at Evolving Approaches
Project Oncology®
Large Cell Neuroendocrine Carcinoma Care: A Look at Evolving Approaches
- Balazs Halmos, MD, MS
Rewriting the Prognosis: Advances in Endometrial Cancer Diagnosis and Treatment
Rewriting the Prognosis: Advances in Endometrial Cancer Diagnosis and Treatment
Project Oncology®
Rewriting the Prognosis: Advances in Endometrial Cancer Diagnosis and Treatment
- Kathleen Moore, MD, MS
Personalized Treatment Pathways in Endometrial Cancer: A Molecular Approach
Personalized Treatment Pathways in Endometrial Cancer: A Molecular Approach
Project Oncology®
Personalized Treatment Pathways in Endometrial Cancer: A Molecular Approach
- Kathleen Moore, MD, MS
Navigating Fertility Preservation in Young Patients With Endometrial Cancer
Navigating Fertility Preservation in Young Patients With Endometrial Cancer
Project Oncology®
Navigating Fertility Preservation in Young Patients With Endometrial Cancer
- Kathleen Moore, MD, MS
Subcutaneous Isatuximab Matches IV in Multiple Myeloma: Insights from IRAKLIA
Subcutaneous Isatuximab Matches IV in Multiple Myeloma: Insights from IRAKLIA
Project Oncology®
Subcutaneous Isatuximab Matches IV in Multiple Myeloma: Insights from IRAKLIA
- Marlene Mimi Maeusli, PhD.
Using FTIR to Support Accurate Tissue Assessment in Colorectal Surgery
Using FTIR to Support Accurate Tissue Assessment in Colorectal Surgery
Clinician's Roundtable
Using FTIR to Support Accurate Tissue Assessment in Colorectal Surgery
- Ashley Baker, MSN, PMHNP
- Heather Allen, PhD
- Ran Li, PhD